We are live on
!
Find out more
VI
Vestcor Inc Portfolio holdings
AUM
$3.63B
1-Year Est. Return
21.49%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$123M
(+3.5%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
18.05%
Holding
1,319
New
163
Increased
386
Reduced
255
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$52.5M |
| 2 |
Duke Energy
DUK
|
+$11.9M |
| 3 |
Cognizant
CTSH
|
+$10.8M |
| 4 |
Realty Income
O
|
+$9.5M |
| 5 |
Cencora
COR
|
+$8.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$18.5M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$17.2M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$14.4M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$14.2M |
| 5 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$9.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 10.61% |
| 3 | Financials | 9.99% |
| 4 | Real Estate | 9.52% |
| 5 | Communication Services | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1051
American Assets Trust
AAT
$1.49B
| $177K | ﹤0.01% |
+9,632
| New | +$180K |
|
1052
DraftKings
DKNG
$11.4B
| $177K | ﹤0.01% |
8,205
| – | – |
|
|
GAP
1053
The Gap Inc
GAP
$6.84B
| $177K | ﹤0.01% |
+7,320
| New | +$194K |
|
|
CSGS
1054
DELISTED
CSG Systems International
CSGS
| $174K | ﹤0.01% |
2,174
-18,567
| -90% | -$1.48M |
|
1055
IonQ
IONQ
$12.3B
| $174K | ﹤0.01% |
6,024
| – | – |
|
1056
Pacira BioSciences
PCRX
$1.02B
| $174K | ﹤0.01% |
7,681
+4,177
| +119% | +$92.8K |
|
1057
Crane Co
CR
$13.1B
| $173K | ﹤0.01% |
1,012
| – | – |
|
1058
Insight Enterprises
NSIT
$3.55B
| $173K | ﹤0.01% |
+2,585
| New | +$211K |
|
1059
State Street SPDR S&P Retail ETF
XRT
$365M
| $173K | ﹤0.01% |
2,150
| – | – |
|
1060
Hecla Mining
HL
$10.2B
| $170K | ﹤0.01% |
+9,133
| New | +$206K |
|
|
JBGS
1061
JBG SMITH
JBGS
$846M
| $170K | ﹤0.01% |
+11,652
| New | +$186K |
|
1062
Solventum
SOLV
$13.5B
| $170K | ﹤0.01% |
2,604
| – | – |
|
|
CVSA
1063
Covista Inc
CVSA
$3.94B
| $167K | ﹤0.01% |
1,450
+548
| +61% | +$58.5K |
|
1064
Perimeter Solutions
PRM
$5.5B
| $164K | ﹤0.01% |
6,704
| – | – |
|
1065
MiMedx Group
MDXG
$626M
| $163K | ﹤0.01% |
41,189
| – | – |
|
1066
LeMaitre Vascular
LMAT
$2.18B
| $162K | ﹤0.01% |
1,480
| – | – |
|
|
PDM
1067
Piedmont Realty Trust
PDM
$1.22B
| $161K | ﹤0.01% |
+24,518
| New | +$191K |
|
1068
Corporacion America
CAAP
$4.11B
| $160K | ﹤0.01% |
+6,317
| New | +$172K |
|
1069
Columbia Sportswear
COLM
$3.19B
| $159K | ﹤0.01% |
2,901
| – | – |
|
1070
Hormel Foods
HRL
$13.9B
| $156K | ﹤0.01% |
6,908
| – | – |
|
1071
Rush Street Interactive
RSI
$3.24B
| $156K | ﹤0.01% |
+7,185
| New | +$138K |
|
1072
Theravance Biopharma
TBPH
$874M
| $156K | ﹤0.01% |
9,591
| – | – |
|
1073
Vicor
VICR
$9.62B
| $154K | ﹤0.01% |
+956
| New | +$158K |
|
1074
Zillow
Z
$7.04B
| $151K | ﹤0.01% |
3,643
| – | – |
|
1075
Erie Indemnity
ERIE
$11.7B
| $147K | ﹤0.01% |
584
-16
| -3% | -$4.29K |
|
Similar funds
JFG
GCM
ACM
APP
SCM
OCM
WB
SL
Vestcor Inc's Q1 2026 Portfolio in Review
As of Q1 2026, Vestcor Inc held 1,319 positions worth $3.63B, up 3.5% from $3.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Vestcor Inc deployed $186M of net new capital in Q1 2026, opening 163 new positions and adding to 386 existing holdings. Its largest new stake was Revolution Medicines: 63,077 shares worth $6.13M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.5M trimmed.
- Vestcor Inc's largest Q1 2026 buy was Revolution Medicines: 63,077 shares worth $6.13M.
- Vestcor Inc added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $52.5M increase.
- Vestcor Inc's biggest Q1 2026 reduction was Bristol-Myers Squibb, cutting an estimated $18.5M.
- Vestcor Inc fully exited Avidity Biosciences in Q1 2026, selling an estimated $14.4M.
- Vestcor Inc's ten largest holdings make up 18% of its $3.63B portfolio in Q1 2026.
- Vestcor Inc opened 163 new positions and closed 127 in Q1 2026.
- Vestcor Inc's portfolio value rose 3.5% quarter-over-quarter to $3.63B.
Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.